Immucell Corp (ICCC) Swings to Q2 Profit
Tweet
Share
E-mailGet Alerts ICCC Hot Sheet
Price: $9.95 -0.3%
Financial Fact:
Other operating expenses: 1.15M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Financial Fact:
Other operating expenses: 1.15M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Immucell Corp (NASDAQ: ICCC) reported Q2 EPS of $0.01, versus ($0.09) reported last year. Revenue for the quarter came in at $1.18 million, versus $1.25 million reported last year.
The Estimize consensus was $0.00 and $0 , respectively.
For earnings history and earnings-related data on Immucell Corp (ICCC) click here.
The Estimize consensus was $0.00 and $0 , respectively.
For earnings history and earnings-related data on Immucell Corp (ICCC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- Corpay agrees to $100M FTC settlement over marketing practices
- B.Riley Assumes Anika Therapeutics (ANIK) at Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
